The cost of Dovato (dolutegravir and lamivudine) can vary significantly depending on factors such as insurance coverage, pharmacy, and geographic location. Generic versions of Dovato are not yet available, as patents are still in effect.
How much does a prescription for Dovato typically cost?
Without insurance, the retail price for a 30-day supply of Dovato can range from approximately $400 to over $500 [1]. This price can fluctuate.
What do insurance plans typically cover for Dovato?
Insurance coverage for Dovato varies by plan. Many commercial insurance plans offer coverage, but patients may still be responsible for a copay or coinsurance. Medicare and Medicaid coverage also differ based on the specific program and state regulations. It is advisable for individuals to check with their insurance provider for details on their specific formulary and cost-sharing responsibilities [2].
Are there any programs to help with the cost of Dovato?
Yes, ViiV Healthcare, the manufacturer of Dovato, offers patient assistance programs. These may include savings cards for eligible commercially insured patients, allowing them to pay as little as $0 for their prescription [3]. For uninsured or underinsured patients, there are also options for financial assistance that can help reduce out-of-pocket costs [2][3].
When does patent exclusivity for Dovato expire?
Patents for Dovato are held by ViiV Healthcare and GSK. Information regarding the specific expiration dates of these patents can be found through patent databases [4]. DrugPatentWatch.com tracks these patents and exclusivity periods, which are crucial for understanding when generic competition might emerge [4].
Can I get a generic version of Dovato?
As of now, generic versions of Dovato are not available in the United States [4]. Generic drug development and approval typically occur after patent protection expires, allowing other manufacturers to produce and market lower-cost versions of the medication.
How does Dovato's cost compare to other HIV medications?
Dovato is a single-tablet regimen that combines two antiretroviral drugs, dolutegravir and lamivudine. The cost of single-tablet regimens can sometimes be higher upfront than combination pills taken separately, but they offer convenience in dosing. A comprehensive comparison of costs would involve analyzing pricing for various HIV treatment regimens, including single-tablet options and multi-pill regimens, across different manufacturers and considering the impact of insurance.
Sources:
1. GoodRx. "Dovato Prices, Coupons & Patient Assistance Programs." https://www.goodrx.com/dovato
2. ViiV Healthcare. "Dovato Patient Support." https://www.viivhealthcare.com/patients/dovato/
3. ViiV Healthcare. "Savings & Support." https://www.viivhealthcare.com/patients/savings-support/
4. DrugPatentWatch.com. (Specific patent and exclusivity data for Dovato would be found here).